scorecardresearch
Add as a preferred source on Google
Tuesday, November 11, 2025
TopicCovid vaccines

Topic: Covid vaccines

Centre has allocated only 15 lakh Covid vaccine doses to Delhi for July: Manish Sisodia

The Deputy CM Monday called India's vaccination drive 'mismanaged' and added that it will take around 16 more months to inoculate Delhi's entire population at the current rate.

Covid vaccine awareness drive to begin tomorrow with help from Muslim clerics to fight ‘rumours’

'Jaan Hai To Jahaan Hai' will be launched from UP's Rampur district. The aim is to tackle vaccine hesitancy across the country, with aid from religious leaders, NGOs and minority organisations.

To launch J&J Covid shot in India, Biological E begins talks with govt lab to test vaccine

Hyderabad-based Biological E has been contracted by American J&J to mass manufacture its one-shot vaccine.

Vaccination picks up pace with 35 lakh shots given in last 24 hrs, but still a long way to go

If India administers an average of 31 lakh doses a day, it will take more than a year to vaccinate the entire population.

Covovax vaccine samples cleared by national drug lab, phase 3 trials could begin by July

Covovax, Novavax's Indian version, will be tested on 1,400 volunteers across 20 cities by Serum Institute, which has already begun production of the Covid vaccine.

Pune cell science centre could soon get Modi govt nod to test and approve Covid vaccines

If given a go-ahead, National Centre for Cell Science will be the 2nd centre after Central Drugs Laboratory, Kasauli, to test Covid-19 vaccines.

Covid immunity lasts for a year, vaccine boost helps fight variants, study says

The study in journal Nature says ability of vaccine-induced antibodies to neutralise variants of concern was comparable to or greater than that against the original strain.

Complex manufacturing, R&D, risks, losses — Bharat Biotech explains why Covaxin is expensive

Bharat Biotech also says Rs 150 per dose price for the government is 'non-competitive' and not sustainable in the long run.

Pfizer, AstraZeneca vaccines provide ‘good protection’ against Delta variant: Lancet study

The study finds Pfizer's Covid vaccine offers 79 per cent protection and the AstraZeneca vaccine, known as Covishield in India, secures 60 per cent protection against Covid strain.

At-home vaccination to taxi ambulance — how this IAS officer in Chennai tackled 2nd Covid wave

A selection of the best news reports, analysis and opinions published by ThePrint this week.

On Camera

ECI reacts to vote chori with passive aggression and no action. Media is doing the same

Opposition parties are doing the best they can, have gathered open-and-shut evidence only to be met with silence and deflection.

No more text-heavy ads, wider scope of services—ICAI’s ethics code overhaul to promote Indian CA firms

Open to public feedback until 26 November, the revised guidelines, among other changes, give CA firms more flexibility to advertise & promote their services.

‘Let them see’: Putin says new nuclear-powered missiles in the making, in message to Washington

At a ceremony felicitating Russian military engineers, Putin highlights Moscow’s 'parity' in defence technologies for the next century.

Bihar is where politics moves, and everything else stands still

Bihar is blessed with a land more fertile for revolutions than any in India. Why has it fallen so far behind then? Constant obsession with politics is at the root of its destruction.